[1] Lackner M,de Hoog GS,Yang,et al.Proposed nomenclature for Pseudallescheria,Scedosporium and related genera[J].Fung Div,2014,67(1):1-10.
[2] 刘英姿.艾滋病患者中结核病的患病情况及发病趋势分析[J].中国医药指南,2013,11(24):261-262.
[3] 何瑞玲.结核病耐药性的流行病学调查分析[J].中国医药指南,2013,11 (1):524-525.
[4] 中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74.
[5] Rainer J,Kaltseis J,de Hoog SG,et al.Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex[J].Antonie Van Leeuwenhoek,2008,93(3):315-22.
[6] Lu Q,Gerrits van den Ende AH,Bakkers JM,et al.Identification of Pseudallescheria and Scedosporium species by three molecular methods[J].J Clin Microbiol,2011,49(3):960-967.
[7] Guarro J,Kantarcioglu AS,Horré R,et al.Scedosporium apiospermum:changing clinical spectrum of a therapy-refractory opportunist[J].Med Mycol,2006,44(4):295-327.
[8] Johnson LS,Shields RK,Clancy CJ.Epidemiology,clinical manifestations,and outcomes of Scedosporium infections among solid organ transplant recipients[J].Transpl Infect Dis,2014,16(4):578-587.
[9] Cimon B,Carrère J,Vinatier JF,et al.Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis[J].Eur J Clin Microbiol Infect Dis,2000,19(1):53-56.
[10] Sedlacek L,Graf B,Schwarz C,et al.Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium[J].J Cyst Fibros,2015,14(2):237-241.
[11] 李秀萍,王玉清,程国栋,等.肺结核患者真菌感染的临床特点及耐药性分析[J].中华医院感染学杂志,2016,26(14):3141-3143.
[12] 孙家斌.老年肺结核合并肺部真菌感染的临床及药敏研究[J].医疗装备,2016,29(2):83-84. |